Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: diabetes

October 4, 2022 Food / Non-pharma applications

The effect of alpha-cyclodextrin on post-prandial glucose excursions, a systematic meta analysis

Alpha-cyclodextrin (αCD) is a bacterial product that is widely used as a food ingredient. In the EU, αCD is regulated

Continue reading

May 27, 2022 Drug delivery / Pharma applications

Insulin Complexation with Cyclodextrins—A Molecular Modeling Approach

Around 5% of the population of the world is affected with the disease called diabetes mellitus. The main medication of

Continue reading

March 16, 2022 Food / Non-pharma applications

Starch-based nanoparticles and cyclodextrin for prebiotics delivery and controlled glucose release in the human gut

In this paper, the preparation and properties of several starch-based nanoparticles (SNPs) and cyclodextrins (CDs) derivatives are reviewed. In particular,

Continue reading

January 20, 2022 Drug delivery / Pharma applications

Insulin Complexation with Cyclodextrins—A Molecular Modeling Approach

The insulin is a peptide hormone, secreted by the pancreas, first discovered in 1922 by Banting and Macleod [5]. This

Continue reading

November 23, 2020 CD derivatives / Drug delivery / Pharma applications

Inclusion complex based on N-acetyl-L-cysteine and arginine modified hydroxypropyl-β-cyclodextrin for oral insulin delivery

Insulin is the most effective drug in the treatment of diabetes mellitus. At present, subcutaneous injection is still the common

Continue reading

Recent Posts

  • Recent books on cyclodextrins
  • β-cyclodextrin complexes with propolis and royal jelly components
  • HPBCD in an approved non-replicating adenoviral vector-based gene therapy product
  • Methyl BCD alters cell envelop studied by AFM
  • Patent application: gamma-cyclodextrin-based polymer for prevention or treatment of cholesterol metabolism-related diseases

Tags

alpha-CD antiviral Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir SBECD Special issue Sugammadex Synthesis wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (13)
  • Analysis (35)
  • CD as API (206)
  • CD derivatives (257)
  • Cosmetics and toilettry (21)
  • Drug delivery (437)
  • E-ducation (54)
  • Environmental (77)
  • Events (160)
  • Food (124)
  • Gene delivery (10)
  • In Hungarian (4)
  • Life sciences (15)
  • Non-pharma applications (215)
  • Other industrial use (59)
  • Pharma applications (703)
  • Supramolecular systems (25)
  • Uncategorized (43)

Top Posts

  • Recent books on cyclodextrins
  • Lanosterol eye drops for cataract treatment
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • 7th European Cyclodextrin Conference
  • Methyl BCD alters cell envelop studied by AFM
  • Patent application: gamma-cyclodextrin-based polymer for prevention or treatment of cholesterol metabolism-related diseases
  • Remdesivir- Dexolve formulation in the space - a book of NASA
  • HPBCD in an approved non-replicating adenoviral vector-based gene therapy product
  • New book: Functionality of Cyclodextrins in Encapsulation for Food Applications
  • New book: Cyclodextrins - new Perspectives

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 524 other subscribers
 

Loading Comments...